Trial Details

COMPLETED
Basic Information
Clinical ID c1092
Identifier NCT03093259
Trial Title ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: ABX464|DRUG: Placebo oral capsule
Participant Information
Sponsor Abivax S.A.
City Innsbruck
Country/Region Austria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2017-11-16
Primary Completion Date 2018-07-25
Completion Date 2019-02-04